What The Drug!? — Drug Design Challenge Live Stream

webinar

Thu, 13 Jun 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

What The Drug!? — Drug Design Challenge Live Stream

Great minds do think alike. Or perhaps they don’t? What goes through the mind of a drug hunter when facing a new challenge?

In “What The Drug?!” we will dive into the thought processes, strategies, and problem-solving techniques of medicinal and computational chemists. The concept: No script. At the beginning of the session, a project is disclosed and its aims are defined. What follows is a freestyle design session where compound design decisions are commented on, providing insights into the creative and analytical processes that drive drug discovery. During the whole event, the viewers are openly invited to comment and share their input.

Anything can happen: Tasks such as “Design a nanomolar binder for target X” or “Suggest five novel scaffolds in compound Y” may arise. With the defined goal in mind, we will use BioSolveIT applications to creatively explore solutions from various angles, innovate compound design, and push the boundaries of what’s possible in drug discovery. Science coupled with ingenuity.

Let’s see how much we can achieve live in a given time frame and if the goals can be reached.

Current news

Enamine's REAL Space October Update
October 8, 2024 12:23 CEST
The October update of Enamine’s REAL Space brings an impressive increase, now offering over 70 billion accessible, drug-like products, compared to 48 billion previously. With a total of 167 reactions now based on in-house knowledge and building blocks, the expansion continues to strengthen one of the largest commercially available compound collections...
Read on
category
Challenge
Winner of the Scientific Challenge Fall 2023: Jeevan Patra with Falcipain Inhibitors
September 20, 2024 10:19 CEST
We are excited to announce that Jeevan Patra is the winner of the BioSolveIT Scientific Challenge Fall 2023. Patra’s research targets Falcipain, a key enzyme in malaria, by identifying selective inhibitors from the Malaria Box, a collection of potent antimalarial candidates by the Medicines for Malaria Venture, Switzerland. With rising...
Read on
2025 Herman Skolnik Award Goes to Prof. Dr. Matthias Rarey
September 19, 2024 17:08 CEST
BioSolveIT is proud to put forth that Prof. Dr. Matthias Rarey, co-founder and a key contributor to the company’s success, shall be recognized with the 2025 Herman Skolnik Award by the American Chemical Society’s Division of Chemical Information (ACS CINF). This award honors his significant contributions to the field of...
Read on